8
panel
FasterCures Advisory Councils Meeting (Invite only)
This meeting brings together the FasterCures Advisory Groups—including the Board, Business Counc
il, and Changemakers nonprofit advisory council—to discuss timely topics across the biomedical research ecosystem.
+ Read More
staff
Brenda Huneycutt, PhD
Brenda Huneycutt, PhD, is a senior director at the Milken Institute, where she directs the expans
ion of MI Health programmatic work internationally across all MI Health portfolios.
+ Read More
article
FasterCures Quarterly Update: July 2023
In This Issue:
Convenings Recap
Policy Updates
FasterCures in the Media
FasterCures in the Communit
y
+ Read More
report
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief
The Milken Institute Center for Public Health and FasterCures have identified three PAHPA 2023 poli
cy priorities that are core to improving and strengthening the nation’s biosecurity and preparedness infrastructure.
+ Read More
report
Toward a National Action Plan for Achieving Diversity in Clinical Trials
Participation in clinical research among racial and ethnic minorities remains low, even though such
groups now represent nearly 40 percent of the US population.
+ Read More
article
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
Submitted electronically
Dr. Robert Califf
Commissioner
US Food and Drug Administration
Silver Spri
ng, MD 20993
Dear Dr. Califf,
+ Read More
article
Milken Institute Announces Key Initiatives at the 2024 Global Conference to Shape the Future of Health
Esther Krofah, executive vice president of Milken Institute Health, (pictured at left) with Emma Wal
msley, CEO of GSK, (right) at the 2024 Milken Institute Global Conference.
+ Read More
article
Discussion Draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
Submitted electronically